Lantern Pharma Inc. (LTRN) › Net IncomeLantern Pharma Inc. (LTRN) — Net IncomeAnnual figures by period end, from SEC filings.2019-12-31: -$2.43M2020-12-31: -$5.91M2021-12-31: -$12.36M2022-12-31: -$14.26M2023-12-31: -$15.96M2024-12-31: -$20.78M2025-12-31: -$17.12M-$17.12M2019-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$17.12M—2026-03-30From 2025-01-012024-12-31-$20.78M—2026-03-30From 2024-01-012023-12-31-$15.96M—2025-03-27From 2023-01-012022-12-31-$14.26M—2024-03-18From 2022-01-012021-12-31-$12.36M—2023-03-20From 2021-01-012020-12-31-$5.91M—2022-03-10From 2020-01-012019-12-31-$2.43M—2021-03-10From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)